Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study

Wilcox, Christopher R; Calvert, Anna; Metz, Jane; Kilich, Eliz; MacLeod, Rachael; Beadon, Kirsten; Heath, Paul T; Khalil, Asma; Finn, Adam; Snape, Matthew D.; Vandrevala, Tushna; Nadarzynski, Tom; Coleman, Matthew A.; Jones, Christine E

doi:10.1097/inf.0000000000002384

Cited by 35 publications

(62 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, midwives would be less likely to support pregnant women becoming vaccinated against SARS-CoV-2 than obstetricians or GPs. These differences in attitudes across professions are consistent with the findings of previous studies on pregnancy or childhood vaccination [ 37 , 38 ]. The reasons are multiple, but a majority of the midwives are waiting for guidelines from their society or the ministry of health.…”

Section: Discussionsupporting

confidence: 91%

Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women

et al. 2021

View full text Add to dashboard Cite

Background Prenatal care providers will play an important role in the acceptance of SARS-Cov-2 vaccination for pregnant women. Objective To determine the perceptions of French prenatal care providers: midwives, general practitioners (GPs) and obstetricians and gynaecologists (Ob-Gyn) regarding SARS-CoV-2 vaccination during pregnancy. Study design An anonymous online survey was sent to members of French professional societies representing prenatal practitioners. The participants were asked to answer questions on their characteristics and give their opinions of the SARS-CoV-2 vaccine for themselves and women who are pregnant or willing to become pregnant. Results Access to the survey was opened from January 11th, 2021, to March 1st, 2021. A total of 1,416 responses were collected from 749 Ob-Gyn, 598 midwives and 69 GPs. Most respondents (86.7% overall, 90.4% for Ob-GYN, 81.1% for GPs and 80.1% for midwives) agreed to receive the SARS-CoV-2 vaccine. Vaccination against SARS-CoV-2 would be offered to pregnant women by 49.4% 95%CI [48.1–50.8] of the participants. Midwives were less likely to recommend vaccination than GP and Ob-Gyn (37.5%, 50.7% and 58.8%, respectively). The multinomial logistic regression revealed that being an obstetrician, working in a group, usually offering a flu vaccine and wanting to be vaccinated against SARS-CoV-2 were positively associated with considering pregnant women for SARS-CoV-2 vaccination. Conclusion Most French prenatal healthcare providers are favourable towards vaccinating pregnant women, but a large minority express reservation. More evidence on safety and involvement by professional organisations will be important to encourage the access of pregnant women to vaccination against SARS-CoV-2.

show abstract

Section: Discussionsupporting

confidence: 91%

Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Knowledge was commonly measured by summary scores of correct answers to factual questions [ 41 , 71 , 97 , 101 , 107 , 109 , 111 , 113 , 119 , 126 ] or self-reported scales, which were more reflective of the provider’s perception of their knowledge [ 56 , 86 , 93 ]. One study found HCP self-rated knowledge of vaccine predicted their recommendation, but knowledge measured by factual questions did not [ 124 ].…”

Section: Resultsmentioning

confidence: 99%

“…Providers knowledgeable about HPV were more likely to recommend the vaccine [ 41 , 50 , 101 , 123 ] (1.9–3 times) [ 41 , 101 ]. Likewise, providers with higher knowledge of RSV in pregnant women [ 86 ], pertussis in post-partum women [ 122 ], general influenza [ 91 ], maternal influenza [ 111 ], and 4CMenB [ 93 ] recommended the respective vaccines more frequently. Japanese providers aware of Guillain–Barre syndrome cases associated with U.S. influenza vaccination were less likely to recommend the vaccine during the 2009 H1N1 pandemic [ 112 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Healthcare Providers’ Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Despite vaccines’ effectiveness in reducing the rate of preventable diseases, vaccine hesitancy has threatened public health and economies worldwide. Healthcare providers’ (HCP) communications and behavior strongly influence patient receptivity and uptake. The goal of this review was to examine HCP vaccine perceptions, knowledge, and reservations and how these attitudes affect their recommendations and vaccination practices. Primary research studies published by 16 September 2020 were searched in PubMed, Web of Science, Embase, CINAHL, and PsycINFO. A 14-item scale was developed for survey study and risk of bias appraisal (SSRBA). In total, 96 papers from 34 countries were included, covering 17 vaccines (HPV and influenza vaccines the most studied). Recommendation was positively associated with provider knowledge and experience, beliefs about disease risk, and perceptions of vaccine safety, necessity, and efficacy. HCP vaccination attitudes and practices varied across specialties, vaccines, and countries; demographic impact was inconclusive. Barriers included anticipation of patient/parental concerns or refusal, lacking clear guidelines, time constraints, and cost. For HPV, vaccines were more often recommended to older, female adolescents and by physicians who discussed sexual health. HCPs are vital advocates for patients and the public, but studies indicated a prevalence of provider hesitancy pertaining to inadequate knowledge, low vaccine confidence, and suboptimal uptake themselves. Improving HCP knowledge and assuring their access to information they deem trustworthy are essential to supporting HCPs‘ role as “trusted messengers” to promote vaccine acceptance.

show abstract

“…38 There is evidence to suggest however that support amongst staff from may grow after implementation of such a service, once they observe that it indeed works in practice. 20,39 Institution-level barriers may include short appointments for antenatal visits, inadequate staffing and resources, lack of a suitable setting and facilities for safe vaccine storage and delivery, and concerns about appropriate insurance and financial reimbursement. 30,35,40 As well ensuring sufficient resources for the delivery of vaccination, it is important to note that resources and training must be in place to deal with any complications or side-effects that arise following vaccination.…”

Section: What Are the Barriers To Routine Implementation Of This Apprmentioning

confidence: 99%

Embedding the delivery of antenatal vaccination within routine antenatal care: a key opportunity to improve uptake

Wilcox

Woodward

Rowe

et al. 2019

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Improving the uptake of vaccination in pregnancy has been highlighted as a priority by the World Health Organisation, yet establishing the optimal location for delivery of the antenatal vaccination program remains a topic of debate internationally. In many countries, antenatal vaccines are usually delivered within Primary Care (under the lead of general practitioners [GPs] or family physicians), yet this often presents a logistic barrier to accessing vaccination, and increasing evidence demonstrates that embedding vaccination within routine antenatal care visits may significantly improve uptake. In this commentary, we discuss recent evidence to support this approach, including anonymous feedback from patients and staff at our own institution, in which a dedicated midwife-led vaccine clinic has recently been set up. Furthermore, we highlight a number of individual and institution-level barriers which would need addressing before this approach can be routinely adopted, and suggest targets for future education and research.

show abstract

Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study

Abstract: Attitudes of pregnant women and healthcare professionals towards clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multi-centre questionnaire study Wilcox,

Cited by 35 publications

References 35 publications

Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women

Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women

Healthcare Providers’ Vaccine Perceptions, Hesitancy, and Recommendation to Patients: A Systematic Review

Embedding the delivery of antenatal vaccination within routine antenatal care: a key opportunity to improve uptake

Contact Info

Product

Resources

About